Insider Selling: Genus plc (LON:GNS) Insider Sells £42,758.16 in Stock

Genus plc (LON:GNSGet Free Report) insider Jorgen Kokke sold 2,186 shares of the business’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of GBX 1,956 ($25.84), for a total value of £42,758.16 ($56,483.70).

Genus Stock Down 2.0 %

Genus stock opened at GBX 1,862 ($24.60) on Thursday. The company has a debt-to-equity ratio of 53.54, a quick ratio of 1.08 and a current ratio of 1.80. The business’s 50-day simple moving average is GBX 1,776.06 and its two-hundred day simple moving average is GBX 1,775.03. The company has a market cap of £1.22 billion, a PE ratio of 15,411.81, a PEG ratio of 2.87 and a beta of 0.37. Genus plc has a fifty-two week low of GBX 1,478 ($19.52) and a fifty-two week high of GBX 2,378 ($31.41).

Genus Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, December 6th. Stockholders of record on Thursday, November 7th will be paid a GBX 21.70 ($0.29) dividend. This is an increase from Genus’s previous dividend of $10.30. The ex-dividend date is Thursday, November 7th. This represents a dividend yield of 1.21%. Genus’s dividend payout ratio is presently 26,666.67%.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft dropped their target price on Genus from GBX 2,300 ($30.38) to GBX 2,150 ($28.40) and set a “buy” rating on the stock in a research note on Wednesday, July 17th.

Read Our Latest Analysis on Genus

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Stories

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.